Article

A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression

Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
Bipolar Disorders (Impact Factor: 4.89). 12/2008; 10(7):806-15. DOI: 10.1111/j.1399-5618.2008.00628.x
Source: PubMed

ABSTRACT Neuropsychological studies of bipolar disorder reveal deficits in a variety of domains, including affective processing, memory, and sustained attention. These findings are difficult to interpret due to the potential confounding effects of mood-stabilizing medications. The present study aims to compare the cognitive performance of medicated and unmedicated subjects with bipolar depression to healthy control subjects.
Unmedicated subjects with bipolar depression (UBD, n = 32), subjects with bipolar depression on therapeutic doses of lithium or valproic acid (MBD, n = 33), and healthy control subjects (HC, n = 52) performed neuropsychological tasks measuring affective processing, visual memory, and sustained attention. Performance measures were covaried with age and mood ratings, where applicable.
With regard to affective processing, the MBD group exhibited greater response latency than the UBD and HC groups. For the same task, the MBD group made more omission errors during the happy condition than in the sad condition. On a task of sustained attention, the MBD group made more errors than the HC group. There were no significant group differences on measures of visual memory.
Deficits in affective processing were found in the medicated group, while unmedicated subjects appear to be unaffected. In particular, the MBD group made more errors during happy conditions, indicating a potential attentional bias in subjects with bipolar depression on mood-stabilizing medications. The present study also implicates impairment in sustained attention for medicated subjects with bipolar disorder, particularly those with the type II variety.

0 Followers
 · 
91 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: In bipolar disorder (BD), lithium and valproate are both reportedly associated with mild cognitive deficits with impaired psychomotor speed and verbal memory ascribed to both while impairments in learning and attention are mainly attributed to valproate. However, there are few direct comparisons of the impact of lithium and valproate on cognitive function in early BD. Using data from the STOP-EM study, we compared neurocognitive functioning in BD patients, who had recently recovered from a first episode of mania, and were on treatment with lithium (n=34) or valproate (n=38), to a comparable sample of healthy controls (HC; n=40), on the domains of processing speed, attention, verbal memory, nonverbal memory, working memory and executive functions. The three groups were comparable on socio-demographic (all p>0.12) and clinical variables (all p>0.08). MANOVA revealed a significant difference between the three groups on overall cognitive functioning (Wilk's lambda=0.644; F= 3.775; p<0.001). On post hoc Tukey test, the valproate group performed poorer on working memory compared to the lithium (p=0.001) and HC groups (p<0.001). There was no significant difference between the lithium and valproate groups on other cognitive domains (all p>0.13). Treatment with valproate and not lithium may be associated with working memory deficits early in the course of BD.
    European Neuropsychopharmacology 09/2014; 25(2). DOI:10.1016/j.euroneuro.2014.09.005 · 5.40 Impact Factor
  • Bulletin of Clinical Psychopharmacology 01/2013; DOI:10.5455/bcp.20130506122642 · 0.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Few studies have analyzed the course of neurocognition in treated children and adolescents with early-onset bipolar disorder (EOBD) and shown improvements in attention, working memory, and verbal memory after treatment. The aim of this study was to determine the progress over two years in neuropsychological performance of a sample of medicated adolescents with EOBD compared to healthy controls (HC). Methods Twenty adolescents, diagnosed in clinical setting as DSM-IV bipolar disorder, treated for two years, euthymic, and 20 gender and age-matched HC were assessed at two moments in reasoning, verbal and visual memory, working memory, speed, visual-motor skills and executive function. Multivariate analyses of variance was carried out to analyze the differences between groups over time, and to monitor the influence of psychotic symptoms and type of mood-stabilizer. Results The entire sample improved on verbal and visual memory tests (verbal recall p<0.01; visual recall p<0.001). Moreover, patients improved more than controls in verbal reasoning (p<0.01), working memory (p<0.01), processing speed (p<0.01) and visual-motor skills (p<0.001). Psychotic symptoms and treatment with lithium were associated with poorer development in executive control tasks. Limitations Sample size was small and groups were re-evaluated in slight different follow-up periods. Doses of antipsychotics drugs over time were not controlled. Conclusions Processing speed and visual-motor skills in the EOBD group normalized during follow-up. Executive functioning, working memory, and verbal and visual memory remained impaired in patients versus controls. The knowledge of cognitive deficits due to normal course of illness or to drug effects allows better therapeutic strategies.
    Journal of Affective Disorders 02/2015; 172:48–54. DOI:10.1016/j.jad.2014.09.041 · 3.71 Impact Factor

Full-text (2 Sources)

Download
59 Downloads
Available from
May 22, 2014